These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5452195)

  • 1. [Radioisotope study of liver function during treatment of lung cancer with cyclophosphane].
    Starinskiĭ VV; Trakhtenberg AKh; Batinov IN
    Med Radiol (Mosk); 1970 Apr; 15(4):32-8. PubMed ID: 5452195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of patients with lung cancer with a combination of nitrosomethylurea and cyclophosphane].
    Perevodchikova NI; Korman NP; Bychkov MB
    Vopr Onkol; 1975; 21(8):21-5. PubMed ID: 170742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced lung cancer treated with cyclophosphamide.
    Davis HL; Ramirez G; Korbitz BC; Ansfield FJ
    Dis Chest; 1969 Dec; 56(6):494-500. PubMed ID: 4187520
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapeutic drugs marked with radioactive isotopes.
    Monod O; Rymer M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):245-9. PubMed ID: 4125742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of lung cancer with cyclophosphamide from the cytological point of view].
    Simecek C
    Bronches; 1971; 21(2):181-5. PubMed ID: 4331189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the effectiveness of N-nitrosomethylurea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea combined with cyclophosphane in inoperable lung cancer].
    Assekritova IV; Perevodchikova NI; Batinov IN; Bychkov MB; Vaarik KhM
    Vestn Akad Med Nauk SSSR; 1978; (9):87-90. PubMed ID: 214971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of protective agents during the treatment of lung neoplasms with cyclophosphane].
    Trakhtenberg AKh; Bergut FA; Trubnikova EN; Shurina NA; Batinov IN
    Sov Med; 1972 Jan; 35(1):40-4. PubMed ID: 5034578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for lung cancer.
    Perevodchikova NI
    Cancer Treat Rep; 1976 Oct; 60(10):1479-81. PubMed ID: 191187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of lung neoplasms with massive single doses of cyclophosphane in combination with the protector cystaphos].
    Batinov IN; Trakhtenberg AK; Trubnikova EN; Sukhin GM
    Vopr Onkol; 1971 Dec; 17(12):83-4. PubMed ID: 5144166
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin and polychemotherapy for treatment of lung cancer.
    Rohwedder JJ; Sagastume E
    Cancer Treat Rep; 1977 Oct; 61(7):1399-401. PubMed ID: 589603
    [No Abstract]   [Full Text] [Related]  

  • 12. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of poorly differentiated lung cancer].
    Melikidze GN
    Vopr Onkol; 1971; 17(8):46-50. PubMed ID: 5002547
    [No Abstract]   [Full Text] [Related]  

  • 14. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
    Tate CF; Viamonte M; Agnew JR
    Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
    [No Abstract]   [Full Text] [Related]  

  • 15. New developments in the treatment of advanced lung cancer.
    Straus MJ
    Am Rev Respir Dis; 1979 Nov; 120(5):967-71. PubMed ID: 228574
    [No Abstract]   [Full Text] [Related]  

  • 16. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 17. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
    Eagan RT; Ingle JN; Frytak S; Rubin J; Kvols LK; Carr DT; Coles DT; O'Fallon JR
    Cancer Treat Rep; 1977 Oct; 61(7):1339-45. PubMed ID: 589599
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphology of pulmonary carcinoma following pre-operative cyclophosphane therapy].
    Kobozeva SA; Trakhtenberg AKh; Batinov IN
    Grudn Khir; 1971; 13(6):61-6. PubMed ID: 5145943
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.